ACADIA Pharmaceuticals, Inc. (ACAD) Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012  
3/13/2013 6:10:10 AM

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced its financial results for the fourth quarter and year ended December 31, 2012.